AUTH/3076/9/18: Director v AstraZeneca – Clinical trial disclosure (outwith scope; no breach) | PMCPA Case

📊

Key facts

⌄

Case number	AUTH/3076/9/18
Parties	Director v AstraZeneca
Topic	Clinical trial disclosure
Complaint received	12 September 2018
Completed	03 July 2019
Applicable Code year	2016
Appeal hearing	No appeal
Decision	No breach (Outwith the scope of the Code)
Clause(s)	Outwith the scope of the Code
Additional sanctions	Not stated
Case summary/report	No summary and no case report (outwith the scope of the Code)

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

🎬 Expert Video Walkthrough

🎬

Video walkthrough — coming for members

Subscribe now and get expert video analysis for every case as we publish them.

Subscribe — from £299/yr

📋

⌄

A complaint was brought by the Director against AstraZeneca.
The subject matter related to clinical trial disclosure.
The PMCPA determined the matter was outwith the scope of the ABPI Code (Applicable Code year: 2016).

⚖️

⌄

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →